Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. 1997

A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
Department of Obstetrics and Gynecology, University Hospital, Innsbruck, Austria.

In the present study the modulatory effects of inflammatory cytokines, interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), on CA-125 release in established ovarian cancer cell lines and in human peritoneal mesothelial cells (HPMC) both grown as monolayers, were investigated. The purity of mesothelial cell cultures were confirmed by the positivity of the cells for vimentin and cytokeratins 8 and 18, and their negativity for markers CD34 and CD68, thus excluding contamination by endothelial cells and macrophages. The preliminary results of CA-125 measurements in the culture medium clearly indicated differences in the pattern of CA-125 expression and release between normal and malignant cells under the influence of inflammatory cytokines. Furthermore, it seems that normal mesothelial cells play a crucial role as a source of CA-125 found in ascitic fluid or in pleural effusions and possibly even in the serum since secretion of this tumor marker into the culture medium was found to be significantly higher in HPMC than in ovarian cancer cells.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010529 Peritoneal Cavity The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the STOMACH. The two sacs are connected by the foramen of Winslow, or epiploic foramen. Greater Sac,Lesser Sac,Omental Bursa,Bursa, Omental,Cavity, Peritoneal,Sac, Greater,Sac, Lesser
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
March 1994, Journal of clinical pathology,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
January 1998, The International journal of biological markers,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
November 2004, ANZ journal of surgery,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
August 1995, Cytokine,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
December 1996, Gynecologic oncology,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
January 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
December 2004, The Annals of pharmacotherapy,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
June 2007, Gynecologic oncology,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
January 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
A G Zeimet, and F A Offner, and C Marth, and K Heim, and H Feichtinger, and G Daxenbichler, and O Dapunt
February 1992, The Netherlands journal of medicine,
Copied contents to your clipboard!